Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Malignant peripheral nerve sheath tumor development during MEK inhibitor treatment: A pre-clinical study and a clinical case series.
Journal: Neuro-oncology advances
Published: April 27, 2026
Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.
Journal: Science advances
Published: January 30, 2026
TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma.
Journal: Science advances
Published: June 20, 2025
A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.
Journal: The Journal of clinical investigation
Published: November 25, 2024
DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 13, 2024
A novel induced pluripotent stem cell model of Schwann cell differentiation reveals NF2 - related gene regulatory networks of the extracellular matrix.
Journal: bioRxiv : the preprint server for biology
Published: May 15, 2024
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia.
Journal: Cancer research communications
Published: May 03, 2024
Correction: Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2024
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.
Journal: Nature medicine
Published: March 19, 2024
Last Updated: 09/26/2026